Novel Ultrasound Protocol Targets Hidden Lipohypertrophy in Insulin-Dependent Diabetes — Canadian Trial Seeks to Improve Glycemic Control

References

1. 1.Australian Diabetes Society. (2023). Australian Clinical Practice Guidelines: Type 1 Diabetes in Adults. https://diabetessociety.com.au/position-statements.asp
2. 2.Blanco, M., Hernández, M. T., Strauss, K. W., & Amaya, M. (2013). Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metabolism, 39(5), 445-453. https://doi.org/10.1016/j.diabet.2013.05.006
3. 3.Campinos, C., Le Floch, J. P., Petit, C., Penfornis, A., Winiszewski, P., & Halimi, S. (2013). An effective approach to prevent lipodystrophy in insulin-treated diabetic patients: the AIR LIP study. Diabetes & Metabolism, 39(6), 523-531. https://doi.org/10.1016/j.diabet.2013.05.002
4. 4.Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., ... & Strauss, K. (2016). New insulin delivery recommendations. Mayo Clinic Proceedings, 91(9), 1231-1255. https://doi.org/10.1016/j.mayocp.2016.06.010
5. 5.Gentile, S., Guarino, G., Giancaterini, A., Guida, P., Strollo, F., & AMD-OSDI Italian Injection Technique Study Group. (2016). A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus, 5(1), 563. https://doi.org/10.1186/s40064-016-1978-y
6. 6.Hirsch, L. J., Gibney, M. A., Albanese, J., Qu, S., Kassler-Taub, K., Klaff, L. J., & Bailey, T. S. (2005). Comparative glycemic control, safety and patient ratings for a new 4mm × 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion, 21(10), 1623-1629. https://doi.org/10.1185/030079905X65277
7. 7.Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2021.101102
8. 8.University of British Columbia. (2024). The Use of Machine Learning Detection of Lipohypertrophy to Improve Glycemic Variability. ClinicalTrials.gov Identifier: NCT05377268. https://clinicaltrials.gov/study/NCT05377268